←
Jim Wilson 🇨🇦1,000 posts
Jim Wilson 🇨🇦 avatar

Jim Wilson 🇨🇦

@LabOccupier

A contract real estate team for #LabTenants in #Canadian #LifeSciences

◷ Joined May 2021▧ 281 Photos and videos
André Picard avatar
⟳ Jim Wilson 🇨🇦 retweeted
André Picard@picardonhealth·Mar 31

Meet the winners of the 2026 Gairdner Awards. Canadian 'baby Nobels' recognize significant advances in human biology and medicine, by @ivansemeniuk @jyangreporter @picardonhealth theglobeandmail.com/canada/a… via @globeandmail @GairdnerAwards

VIDO avatar
⟳ Jim Wilson 🇨🇦 retweeted
VIDO@VIDOInterVac·20 Sep 2025

Did you know? VIDO has developed 50+ animal models to study infectious diseases! 🧬🐄🐖🐔 These models are critical for research, helping scientists understand diseases & accelerate vaccine and treatment development—protecting both human & animal health. #VIDOis50

Post attachment
VIDO avatar
⟳ Jim Wilson 🇨🇦 retweeted
VIDO@VIDOInterVac·12 Sep 2025

Three years ago, we celebrated the completion of construction of our Vaccine Development Centre (VDC). The VDC’s manufacturing capabilities for human and animal vaccines supports Canada’s emergency response for possible future pandemics. #VIDOis50

Post attachment
Science Magazine avatar
⟳ Jim Wilson 🇨🇦 retweeted
Science Magazine@ScienceMagazine·21 Jul 2025

The mantra “location, location, location” isn’t just about real estate. For life scientists, more than 50% of their productivity can be attributed to the institution where they work, according to a new study. @ScienceCareers scim.ag/44V9Vxo

Bo Wang avatar
⟳ Jim Wilson 🇨🇦 retweeted
Bo Wang@BoWang87·9 Jul 2025

Just had the pleasure of being interviewed by @Nature on the rise of AI in digital pathology. With growing workloads and global shortages of pathologists, the field is turning to AI not as a luxury—but as a necessity. Full article: nature.com/articles/d41586-0… In the article, I discuss how recent advances in foundation models like UNI-2 and CONCH are redefining what’s possible in cancer diagnostics. Trained on hundreds of millions of pathology patches, these models go beyond classification: they enable molecular subtyping, caption generation, and even zero-shot inference. But while the hype is real, so are the challenges. Cross-site generalization, lack of external validation, and regulatory hurdles remain major barriers. We must invest in robust benchmarking, multi-institutional trials, and trustworthy model design to ensure AI truly supports—not replaces—clinical judgment. Digital pathology isn’t the future—it’s already here. Let’s make it safe, scalable, and equitable. @UHN_Research @PMResearch_UHN @VectorInst @UofT

Post attachmentPost attachment
VIDO avatar
⟳ Jim Wilson 🇨🇦 retweeted
VIDO@VIDOInterVac·10 Jun 2025

Today we had an excellent chat with several Saskatchewan MLAs sharing the importance of infectious disease research and its worldwide impact. #CanadianResearch

Post attachment
University Health Network avatar
⟳ Jim Wilson 🇨🇦 retweeted
University Health Network@UHN·30 May 2025

"There is a cohort of talent unlike we have ever seen before that we can compete for." Dr. @bradwouters, EVP of Science & Research at UHN, gives @CBCTheNational an inside look at Canada Leads, an initiative to recruit 100 top early-career scientists: cbc.ca/player/play/video/9.6…